Atnaujinkite slapukų nuostatas

2019 Nelson's Pediatric Antimicrobial Therapy 25th Revised edition [Minkštas viršelis]

  • Formatas: Paperback / softback, 316 pages, aukštis x plotis: 165x114 mm
  • Išleidimo metai: 30-Dec-2018
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610022106
  • ISBN-13: 9781610022101
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 316 pages, aukštis x plotis: 165x114 mm
  • Išleidimo metai: 30-Dec-2018
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610022106
  • ISBN-13: 9781610022101
Kitos knygos pagal šią temą:
This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of all infectious diseases in children.

For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobials and include complete information about dosing regimens. In response to growing concerns about overuse of antibiotics, the program includes guidelines on when not to prescribe antibiotics.

Now in color to help you find the best options quickly!

New in the 25th edition:

•    Includes recommendations for new intravenous broad-spectrum beta-lactam/beta-lactamase inhibitor combinations.
•    Provides options for treatment of increasing resistance in Escherichia coli for urinary tract infections.
•    Includes updates for management of diarrhea, including recommendations for Giardia with tinidazole and nitazoxanide as drugs of choice, based on the new Infectious Diseases Society of America (IDSA) guidelines.
•    Clarifies specific, new, and evolving recommendations about antifungal therapeutic drug levels for several invasive fungal infections, particularly in immunocompromised children.
•    Reorganizes antiviral table for easier reading: common viral pathogens are in one table and HIV, hepatitis B, and hepatitis C are in a second table.
•    Provides guidance for neonates during the ongoing cefotaxime shortage, including alternatives to achieve similar antibacterial activity in similar tissue sites, with a similar safety profile.
•    Includes updates, such as new information on drug therapy and steroid therapy for neurocysticercosis, incorporating the new IDSA and American Society of Tropical Medicine and Hygiene guidelines.
•    Incorporates new IDSA coccidioidomycosis guidelines in updated recommendations.
•    Simplifies navigation with color-coded tabs and tables that make it easier to find the best treatment options for susceptibility of bacterial, fungal, viral, and parasitic pathogens.

This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of all infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.

Recenzijos

This is a highly valuable resource for any clinician taking care of children with infections from the community to the ICU. This book easily fits into a lab coat pocket, and when a diagnosis or pathogen is known, pulled out to look up the treatment with dosing within minutes. Victoria Konold, MD, University of Chicago Pritzker School of Medicine

Introduction vii
Notable Changes to 2019 Nelson's Pediatric Antimicrobial Therapy, 25th Edition xi
1 Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
1(8)
2 Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
9(8)
3 How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
17(4)
4 Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus
21(8)
5 Antimicrobial Therapy for Newborns
29(30)
A Recommended Therapy for Selected Newborn Conditions
30(21)
B Antimicrobial Dosages for Neonates
51(4)
C Aminoglycosides
55(1)
D Vancomycin
56(1)
E Use of Antimicrobials During Pregnancy or Breastfeeding
56(3)
6 Antimicrobial Therapy According to Clinical Syndromes
59(68)
A Skin and Soft Tissue Infections
62(6)
B Skeletal Infections
68(3)
C Eye Infections
71(4)
D Ear and Sinus Infections
75(3)
E Oropharyngeal Infections
78(3)
F Lower Respiratory Tract Infections
81(13)
G Cardiovascular Infections
94(7)
H Gastrointestinal Infections
101(7)
I Genital and Sexually Transmitted Infections
108(4)
J Central Nervous System Infections
112(5)
K Urinary Tract Infections
117(2)
L Miscellaneous Systemic Infections
119(8)
7 Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
127(28)
A Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
128(2)
B Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
130(2)
C Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
132(2)
D Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
134(21)
8 Preferred Therapy for Specific Fungal Pathogens
155(18)
A Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
156(2)
B Systemic Infections
158(14)
C Localized Mucocutaneous Infections
172(1)
9 Preferred Therapy for Specific Viral Pathogens
173(16)
A Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
174(1)
B Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
174(2)
C Preferred Therapy for Specific Viral Pathogens
176(13)
10 Preferred Therapy for Specific Parasitic Pathogens
189(22)
A Selected Common Pathogenic Parasites and Suggested Agents for Treatment
190(2)
B Preferred Therapy for Specific Parasitic Pathogens
192(19)
11 Alphabetic Listing of Antimicrobials
211(30)
A Systemic Antimicrobials With Dosage Forms and Usual Dosages
213(21)
B Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
234(7)
12 Antibiotic Therapy for Children Who Are Obese
241(4)
13 Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
245(2)
14 Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
247(16)
A Postexposure Antimicrobial Prophylaxis to Prevent Infection
249(7)
B Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
256(1)
C Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
257(1)
D Surgical/Procedure Prophylaxis
258(5)
Appendix: Nomogram for Determining Body Surface Area 263(2)
References 265(24)
Index 289